The Way We Do Europe: Subsidiarity and theSubstantiveDemocratic Deficit

It Ain’t What You Do (But the Way That You Do It): Will Safety II Transform the Way We Do Patient Safety; Comment on “False Dawns and New Horizons in Patient Safety Research and Practice”

Mannion and Braithwaite outline a new paradigm for studying and improving patient safety – Safety II. In this response, I argue that Safety I should not be dismissed simply because the safety management strategies that are developed and enacted in the name of Safety I are not always true to the original philosophy of ‘systems thinking.’

Why do we teach physiology the way we do? An analysis of national characteristics.

In 1919 Dr. Bernardo A. Houssay (later Nobel laureate) was appointed full-time Professor of Physiology in the School of Medicine at the University of Buenos Aires. Soon after his appointment he obtained full-time positions for some of his colleagues also. He argued that, in physiology, teaching and research should be associated. At this same time, laboratory work, with active participation by s...

Diagnostic and therapeutic challenges for dermatologists: What shall we do when we don’t know what to do?

What shall we do when we have done everything we could for the diagnosis and treatment of a patient, but were not successful? What shall we do when there is no definite treatment for a patient? What shall we do when we have no diagnosis or treatment for a patient? Some useful suggestions are presented here to get rid of these situations.

Do We Know What We Do not Know? A Response to Celine Bonnet

Could apoptosis change the way we do PRK?

Just when we thought photorefractive keratectomy (PRK) had achieved a level of safety and predictability in correcting refractive errors in our patients, new wounding healing information regarding apoptosis (programmed cell death) surfaces to show us that the way we remove the corneal epithelium matters a great deal in how the corneal stroma responds to our treatment.1 Excimer laser manufacture...